Some results have been hidden because they may be inaccessible to you.Show inaccessible results
Once Monthly Dosing | Fast & Lasting Symptom Relief
SponsoredLearn About Mechanism Of Action Info On How This Treatment Option Targets & Blocks IL-17A. HCPs, Find Resources On Clinical Results, Dosing, Established Safety Profile & More Here.Prescribing Information · FDA-Approved Option · Dosing & Administration · Safety & Efficacy Info
Types: HCP Information, IV Dosing, Helpful Dosing Resources, Start FormILUMYA® (tildrakizumab-asmn) | ILUMYA® & the Long Haul
SponsoredView ILUMYA® Resources on the Official Patient Website & Start Treatment. Find out if ILUMYA® is a Treatment Option for You. Speak to Your Doctor.